Literature DB >> 21900421

Structural modelling and mutagenesis of human cytomegalovirus alkaline nuclease UL98.

Alison L Kuchta1, Hardik Parikh2, Yali Zhu3, Glen E Kellogg2, Deborah S Parris3, Michael A McVoy1.   

Abstract

Human cytomegalovirus encodes an alkaline nuclease, UL98, that is highly conserved among herpesviruses and has both endonuclease (endo) and exonuclease (exo) activities. This protein is thought to be important for viral replication and therefore represents a potential target for antiviral development; however, little is known about its structure or role in viral replication. Comparative structural modelling was used to build a model of UL98 based on the known structure of shutoff and exonuclease protein from Kaposi's sarcoma-associated herpesvirus. The model predicts that UL98 residues D254, E278 and K280 represent the critical aspartic acid, glutamic acid and lysine active-site residues, respectively, while R164 and S252 correspond to residues proposed to bind the 5' phosphate of the DNA substrate. UL98 with an amino-terminal hexahistidine tag was expressed in Escherichia coli, purified by affinity chromatography and confirmed to have exo and endo activities. Amino acid substitutions D254A, E278A, K280A and S252A virtually eliminated exo and endo activities, whereas R164A retained full endo activity but only 10 % of the exo activity compared with the wild-type enzyme. A mutant virus lacking UL98 was viable but severely attenuated for replication, while one expressing UL98(R164A) replicated normally. These results confirm the utility of the model in representing the active-site region of UL98 and suggest a mechanism for the differentiation of endonuclease and exonuclease activities. These findings could facilitate the exploration of the roles of alkaline nucleases in herpesvirus replication and the rational design of inhibitors that target their enzymic activities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21900421      PMCID: PMC3352332          DOI: 10.1099/vir.0.034876-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  38 in total

1.  A bridge crosses the active-site canyon of the Epstein-Barr virus nuclease with DNase and RNase activities.

Authors:  Marlyse Buisson; Thibault Géoui; David Flot; Nicolas Tarbouriech; Maaike E Ressing; Emmanuel J Wiertz; Wim P Burmeister
Journal:  J Mol Biol       Date:  2009-06-16       Impact factor: 5.469

2.  Structural, functional, and evolutionary relationships between lambda-exonuclease and the type II restriction endonucleases.

Authors:  R A Kovall; B W Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

Review 3.  Cytomegalovirus infection in immunocompetent and immunocompromised individuals--a review.

Authors:  Z Vancíková; P Dvorák
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2001-08

4.  Suppression of amber nonsense mutations of herpes simplex virus type 1 in a tissue culture system.

Authors:  A H Patel; J H Subak-Sharpe; N D Stow; H S Marsden; J B Maclean; D J Dargan
Journal:  J Gen Virol       Date:  1996-02       Impact factor: 3.891

5.  Replication, recombination and packaging of amplicon DNA in cells infected with the herpes simplex virus type 1 alkaline nuclease null mutant ambUL12.

Authors:  Iain M Porter; Nigel D Stow
Journal:  J Gen Virol       Date:  2004-12       Impact factor: 3.891

6.  Site-directed mutagenesis in a conserved motif of Epstein-Barr virus DNase that is homologous to the catalytic centre of type II restriction endonucleases.

Authors:  Ming-Tsan Liu; Hsien-Ping Hu; Tsuey-Ying Hsu; Jen-Yang Chen
Journal:  J Gen Virol       Date:  2003-03       Impact factor: 3.891

7.  Herpes simplex virus type 1 DNase: functional analysis of the enzyme expressed by recombinant baculovirus.

Authors:  E Kehm; M Göksu; S Bayer; C W Knopf
Journal:  Intervirology       Date:  1998       Impact factor: 1.763

8.  Herpes simplex virus 1 alkaline nuclease is required for efficient egress of capsids from the nucleus.

Authors:  L Shao; L M Rapp; S K Weller
Journal:  Virology       Date:  1993-09       Impact factor: 3.616

9.  The product of a 1.9-kb mRNA which overlaps the HSV-1 alkaline nuclease gene (UL12) cannot relieve the growth defects of a null mutant.

Authors:  R Martinez; L Shao; J C Bronstein; P C Weber; S K Weller
Journal:  Virology       Date:  1996-01-15       Impact factor: 3.616

10.  The human cytomegalovirus UL98 gene transcription unit overlaps with the pp28 true late gene (UL99) and encodes a 58-kilodalton early protein.

Authors:  B L Adam; T Y Jervey; C P Kohler; G L Wright; J A Nelson; R M Stenberg
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more
  4 in total

1.  The DNase Activity of Kaposi's Sarcoma-Associated Herpesvirus SOX Protein Serves an Important Role in Viral Genome Processing during Lytic Replication.

Authors:  Timsy Uppal; Dylan Meyer; Andrea Agarwal; Subhash C Verma
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

2.  Varicella-zoster virus open reading frame 48 encodes an active nuclease.

Authors:  Niklaus H Mueller; Don Gilden; Randall J Cohrs
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

3.  Mitochondrial nucleases ENDOG and EXOG participate in mitochondrial DNA depletion initiated by herpes simplex virus 1 UL12.5.

Authors:  Brett A Duguay; James R Smiley
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

4.  Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL.

Authors:  Zohaib Alam; Zainab Al-Mahdi; Yali Zhu; Zachary McKee; Deborah S Parris; Hardik I Parikh; Glen E Kellogg; Alison Kuchta; Michael A McVoy
Journal:  Antiviral Res       Date:  2014-12-10       Impact factor: 5.970

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.